Relapsed Cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00441 | Gemcitabine | A nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01262 | Decitabine | 0 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 0 | Active Not Recruiting | 1 |
| DB09331 | Daratumumab | 1 | Terminated | 1 |
| DB01234 | Dexamethasone | 1 | Terminated | 1 |
| DB00480 | Lenalidomide | 1 | Terminated | 1 |
| DB11967 | Binimetinib | 1 / 2 | Recruiting | 1 |
| DB14707 | Cemiplimab | 1 / 2 | Recruiting | 1 |
| DB08865 | Crizotinib | 1 / 2 | Recruiting | 1 |
| DB13874 | Enasidenib | 1 / 2 | Terminated | 1 |
| DB09053 | Ibrutinib | 1 / 2 | Recruiting | 1 |
| DB12130 | Lorlatinib | 1 / 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
| DB00073 | Rituximab | 1 / 2 | Recruiting | 1 |
| DB11581 | Venetoclax | 1 / 2 | Terminated | 1 |
| DB15719 | Belantamab mafodotin | 2 | Not Yet Recruiting | 1 |
| DB06769 | Bendamustine | 2 | Recruiting | 1 |
| DB01234 | Dexamethasone | 2 | Not Yet Recruiting | 1 |
| DB16672 | Epcoritamab | 2 | Recruiting | 1 |
| DB14811 | Isatuximab | 2 | Not Yet Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB00642 | Pemetrexed | 2 | Recruiting | 1 |
| DB08910 | Pomalidomide | 2 | Not Yet Recruiting | 1 |
| DB15035 | Zanubrutinib | 2 | Recruiting | 1 |
| DB16655 | Teclistamab | 4 | Not Yet Recruiting | 1 |
| DB06273 | Tocilizumab | 4 | Not Yet Recruiting | 1 |